Supervised Walking Groups as a Model to Increase Physical Activity in Type 2 Diabetes

NCT ID: NCT01115205

Last Updated: 2010-05-05

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

59 participants

Study Classification

INTERVENTIONAL

Study Start Date

2006-03-31

Study Completion Date

2009-01-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of the study is to evaluate the impact of an exercise programme organized into supervised walking groups on metabolic control, functional capacity and overall quantity of physical activity in subjects with type 2 diabetes.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Regular, moderate-intensity physical activity can attenuate hyperglycemia in subjects with type 2 diabetes. In addition, these programmes may favourably affect several other cardiovascular risk factors in these subjects. However, it still remains unclear how this evidence can be transferred into clinical practice, considering the very large number of diabetic patients and the characteristics of this population, made up predominantly of elderly, sedentary and overweight patients. In this regard, a realistic approach to this issue requires simple and easily available intervention models.

Walking is a typical mild-moderate aerobic physical activity which is easy to organize and does not require specific skills or preliminary sophisticated medical evaluations. This activity could therefore fit well with the need of involvement of large numbers of patients in different logistic situations. However, it has been reported that, due to the low walking speed typical of type 2 diabetic subjects, self-paced walking is inadequate to obtain a significant metabolic improvement in these subjects.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Type 2 Diabetes

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Supervised walking groups

Patients included in walking groups, under the supervision of a qualified personal trainer.

Group Type EXPERIMENTAL

Supervised walking

Intervention Type BEHAVIORAL

Walk training, 3 sessions per week for 4 months, under the supervision of a qualified personal trainer.

Controls

Patients receiving the standard counselling procedures of the Verona Diabetic Clinic.

Group Type ACTIVE_COMPARATOR

Standard counselling procedure

Intervention Type BEHAVIORAL

Verbal and written information about the benefits of exercise and instructions aimed to encourage physical activity. In addition, one group session of counselling on these issues.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Supervised walking

Walk training, 3 sessions per week for 4 months, under the supervision of a qualified personal trainer.

Intervention Type BEHAVIORAL

Standard counselling procedure

Verbal and written information about the benefits of exercise and instructions aimed to encourage physical activity. In addition, one group session of counselling on these issues.

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* diabetes known for at least 2 yr
* physical inactivity
* haemoglobin (Hb)A1c between 6.5-9.9%
* treatment with oral hypoglycaemic agents alone or associated with a bed-time insulin injection
* willingness to participate in a programme of regular physical activity

Exclusion Criteria

* moderate-severe autonomic or somatic neuropathy
* severe lower limb vasculopathy
* pre-proliferative or proliferative active retinopathy
* moderate to severe chronic renal failure
* unstable angina or recent (in the previous 3 months) myocardial infarction
* acute intercurrent diseases
* acute metabolic decompensation (blood glucose \>300 mg/dl or ketonuria in two consecutive checks)
* use of beta-blocker drugs
* subjects unable to complete a 6-min walk test
Minimum Eligible Age

50 Years

Maximum Eligible Age

75 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Universita di Verona

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Department of Medicine, Universita di Verona

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Paolo Moghetti, M.D., Ph.D.

Role: PRINCIPAL_INVESTIGATOR

Universita di Verona

References

Explore related publications, articles, or registry entries linked to this study.

Negri C, Bacchi E, Morgante S, Soave D, Marques A, Menghini E, Muggeo M, Bonora E, Moghetti P. Supervised walking groups to increase physical activity in type 2 diabetic patients. Diabetes Care. 2010 Nov;33(11):2333-5. doi: 10.2337/dc10-0877.

Reference Type DERIVED
PMID: 20980426 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

CE 1264

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.